In response to the growing health crisis in Libya, the United Nations Sanctions Committee has approved the release of €100 million, from the Central Bank of Libya to WHO to ensure the provision of essential medicines, vaccines and medical supplies for the whole of the country. It is expected that the first tranche of supplies will cover eight weeks of consumption.
With the initial €100 million funding, WHO will undertake the following activities:
Procure essential medicines and medical supplies as listed by the Libyan authorities and validated by WHO.
Work closely with current health authorities in Libya to draw up drug distribution plans and put systems in place to ensure that all medicines and medical supplies are received, stored, inventoried and distributed according to needs.
Establish an operational hub (in Malta and/or Brindisi), where WHO will work closely with WFP to optimize available logistic capacity.
Use all available transport options to distribute medical supplies to different areas within Libya.
With local health authorities, conduct regular joint inspections of health care facilities to monitor the availability and use of the drugs and medical supplies.
Work closely with Health Cluster partners to determine and respond to further medical supplies and transport needs.
Related programmes
Essential medicines and pharmaceutical policies
